Adell Harriman & Carpenter Inc. Raises Position in Intuitive Surgical, Inc. $ISRG

Adell Harriman & Carpenter Inc. raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 705 shares of the medical equipment provider’s stock after acquiring an additional 60 shares during the quarter. Adell Harriman & Carpenter Inc.’s holdings in Intuitive Surgical were worth $383,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Chilton Capital Management LLC increased its position in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares during the period. Elite Financial Inc. bought a new position in Intuitive Surgical during the 1st quarter valued at approximately $26,000. TD Capital Management LLC raised its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC bought a new position in Intuitive Surgical during the 1st quarter valued at approximately $30,000. Finally, Princeton Global Asset Management LLC bought a new position in Intuitive Surgical during the 2nd quarter valued at approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the sale, the director directly owned 1,074 shares in the company, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares in the company, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 96,011 shares of company stock valued at $50,309,042. 0.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent analyst reports. Truist Financial set a $620.00 price target on Intuitive Surgical and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Evercore ISI upped their price target on Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Rothschild & Co Redburn boosted their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Finally, Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Price Performance

ISRG stock opened at $530.02 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company has a market cap of $190.00 billion, a P/E ratio of 70.11, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61. The stock’s fifty day moving average price is $463.16 and its 200-day moving average price is $498.23.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period last year, the firm earned $1.84 earnings per share. The company’s quarterly revenue was up 22.9% on a year-over-year basis. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.